e2e Pharma, a private brand end-to-end manufacturer of CBD and non-CBD branded topicals and ingestibles marketed directly to customers online and through national retail chains, is expanding its fully functional 30,000-square-foot manufacturing facility with four clean rooms and storage.
e2e's GMP-certified manufacturing facility will assist brands in developing 12-15 distinct white and private label form factors, including topicals like lotions, creams, and balms, non-aerosol sprays, and roll-ons, and ingestible like gummies, soft gels, and tinctures. The facility can accommodate around 100,000 units per week each shift on average.
Founder of e2e, Shannon Bard, stated, "We understand the game that our clients are playing, and are well-positioned to offer them the high-quality end-to-end service that their audience is asking for. Our team has more than 30 years of experience in the consumer-packaged goods (CPG) space, and by bringing this sophisticated approach, we understand that sellers need the products to be well-made, safe, efficacious, and delivered on time in order to be attractive to their retail partners."
e2e items are supplied nationally by prominent retail brands, with food and pharmacy placement at stores and mega-retail store chains such as CVS, Walgreens, Whole Foods, Kroger, and Dollar General. e2e also provides drop shipping to clients' customers.
"Branding and third-party production can be difficult to discover and even more difficult to get properly," Bard continued. As shown by the fact that we are already producing goods for today's prominent CBD brands in retail, e2e is a trusted partner."
e2e also creates non-CBD branded items through its white and private label services, such as plant-based and plant-adaptogen health and wellness products, topicals, ingestible, and beauty products, in addition to CBD. The purpose of e2e is to continue diversifying its client base and to manufacture end-to-end product solutions for a diverse range of global brands.
Featured Image: Megapixl @Designer491
